[1] Rathmann W,
Ziegler D,
Jahnke M,
Haastert B,
Gries FA (1993) Mortality in diabetic patients with cardiovascular autonomic neuropathy. Diabet Med 10:820–824
[2] Liao D,
Carnethon M,
Evans GW,
Cascio WE,
Heiss G (2002) Lower heart rate variability is associated with the development of coronary heart diseases in individuals with diabetes: the Atherosclerosis Risk in Communities Study.
Diabetes 51:3524–3531
[3] Jeffcoate W,
Lima J,
Nobrega L (2000) The Charcot foot.
Diabet Med 17:253–258
[4] Sohn MW,
Lee TA,
Stuck RM,
Frykberg RG,
Budiman-Mak E (2009) Mortality risk of Charcot arthropathy compared with that of diabetic foot ulcer and diabetes alone.
Diabetes Care 32:816–821
[5] American Diabetes Association (1998) Consensus development conference on the diagnosis of coronary heart disease in people
with diabetes.
Diabetes Care 21:1551–1559
[6] Miller TD,
Redberg RF,
Wackers FJT (2006) Screening asymptomatic diabetic patients for coronary artery disease: why not? J Am Coll Cardiol 48:761–764
[7] Young LH,
Wackers FJ,
Chyun DA et al (2009) Cardiac outcomes after screening for asymptomatic coronary artery disease in patients with type 2 diabetes: the DIADstudy: a randomized controlled trial. JAMA 301:1547–1555
[8] Inzucchi SE (2001) Noninvasive assessment of the diabetic patient for coronary artery disease.
Diabetes Care 24:1519–1521
[9] Ritchie JL,
Bateman TM,
Bonow RO et al (1995) Guidelines for clinical use of cardiac radionuclide imaging.
A report of the American Heart Association/American College of Cardiology Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures,
Committee on Radionuclide Imaging, developed in collaboration with the American Society of Nuclear Cardiology.
Circulation 91:1278–1303
[10] Dal Porto R,
Faletra F,
Picano E,
Pirelli S,
Moreo A,
Varga A (2001) Safety,
feasibility,
and diagnostic accuracy of accelerated high-dose
dipyridamole stress echocardiography.
Am J Cardiol 87:520–524
[11] Ewing DJ,
Clarke BF (1982) Diagnosis and management of diabetic autonomic neuropathy.
Br Med J 285:916–918
[12] Young MJ,
Boulton AJM,
Macleod AF,
Williamd DRR,
Sonksen PK (1993) A multicentre study of the prevalence of diabetic peripheral neuropathy in the UK hospital clinic population.
Diabetologia 36:150–154
[13] Tomas MB,
Patel M,
Marvin SE,
Palestro CJ (2000) The diabetic foot.
Br J Radiol 73:443–450
[14] Agatston AS,
Janowitz WR,
Hildner FJ,
Zusmer NR,
Viamonte M Jr,
Detrano R (1990) Quantification of coronary artery calcium using ultrafast computed tomography.
J Am Coll Cardiol 15:827–832
[15] Meijboom WB,
Van Mieghem CAG,
van Pelt N et al (2008) Comprehensive assessment of coronary artery stenoses: computed tomography coronary angiography versus conventional coronary angiography and correlation with fractional flow reserve in patients with stable angina.
J Am Coll Cardiol 52:636–643
[16] Austen WG,
Edwards JE,
Frye RL et al (1975) A reporting system on patients evaluated for coronary artery disease.
Report of the ad hoc committee for grading of coronary artery disease,
council on cardiovascular surgery,
American Heart Association.
Circulation 51:5–40
[17] Pitocco D,
Marano R,
Di Stasio E et al (2014) Atherosclerotic coronary plaque in subjects with diabetic neuropathy: the prognostic cardiovascular role of Charcot neuroarthropathy-a case-control study.
Acta Diabetol 51:587–593
[18] Jeffcoate WJ,
Game F,
Cavanagh PR (2005) The role of proinflammatory cytokines in the cause of neuropathic osteoarthropathy (acute Charcot foot) in diabetes.
Lancet 366:2058–2061
[19] Libby P,
Sukhova G,
Lee RT,
Galis ZS (1995) Cytokines regulate vascular functions related to stability of the atherosclerotic plaque.
J Cardiovasc Pharmacol 25:S9–S12
[20] Tamaru M,
Tomura K,
Sakamoto S,
Tezuka K,
Tamatani T,
Narumi S (1998) Interleukin-1 beta induces tissue- and cell-specific expression of adhesion molecules in vivo.
Arterioscler Thromb Vasc Biol 18:1292–1303
[21] Katano H,
Yamada K (2007) Analysis of calciumin carotid plaques with Agatston scores for appropriate selection of surgical intervention. Stroke 38:3040–3044
[22] An C,
Lee HJ,
Lee HS et al (2014) CT-based abdominal aortic calcification score as a surrogate marker for predicting the presence of asymptomatic coronary artery disease.
Eur Radiol 24:2491–2498
[23] Aboyans V,
McClelland RL,
Allison MA et al (2011) Lower extremity peripheral artery disease in the absence of traditional risk factors.
TheMulti-Ethnic Study of Atherosclerosis.
Atherosclerosis 214:169–173
[24] Bergis D,
Bergis PM,
Hermanns N,
Zink K,
Haak T (2014) Coronary artery disease as an independent predictor of survival in patients with type 2 diabetes and Charcot neuro-osteoarthropathy. Acta Diabetol 51:1041–1048
[25] Beck MO,
Silveiro SP,
Friedman R,
Clausell N,
Gross JL (1999) Asymptomatic coronary artery disease is associated with cardiac autonomic neuropathy and diabetic nephropathy in type 2 diabetic patients.
Diabetes Care 22:1745–1747
[26] Min JK,
Labounty TM,
Gomez MJ et al (2014) Incremental prognostic value of coronary computed tomographic angiography over coronary artery calcium score for risk prediction of major adverse cardiac events in asymptomatic diabetic individuals. Atherosclerosis 232:298–304
[27] Marano R,
Pitocco D,
Di Stasio E et al (2015) MDCT assessment of CAD in type-2 diabetic subjects with diabetic neuropathy: the role of Charcot neuro-arthropathy.
Eur Radiol